GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 57 filers reported holding GT BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 2.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,858 | -21.5% | 20,158 | +1.7% | 0.00% | – |
| Q2 2023 | $6,185 | +38556.2% | 19,823 | -30.2% | 0.00% | -100.0% |
| Q1 2023 | $16 | +14.3% | 28,415 | +84.2% | 0.00% | 0.0% |
| Q4 2022 | $14 | -99.8% | 15,423 | +187.0% | 0.00% | – |
| Q3 2022 | $9,000 | -18.2% | 5,374 | +45.6% | 0.00% | – |
| Q2 2022 | $11,000 | +22.2% | 3,691 | +14.2% | 0.00% | – |
| Q1 2022 | $9,000 | -25.0% | 3,231 | -16.9% | 0.00% | – |
| Q4 2021 | $12,000 | -47.8% | 3,888 | +13.9% | 0.00% | -100.0% |
| Q3 2021 | $23,000 | +475.0% | 3,414 | +1141.5% | 0.00% | – |
| Q2 2021 | $4,000 | -55.6% | 275 | -79.6% | 0.00% | – |
| Q1 2021 | $9,000 | – | 1,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crumly & Associates Inc. | 32,163 | $93,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 20,075 | $58,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,260 | $81,000 | 0.00% |
| Sigma Planning Corp | 21,400 | $62,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 30,000 | $86,000 | 0.00% |
| Gordian Capital Singapore Pte Ltd | 35,000 | $3,000 | 0.00% |
| Welch Group, LLC | 10,000 | $29,000 | 0.00% |
| Renaissance Technologies | 186,300 | $537,000 | 0.00% |
| BRIGHTON JONES LLC | 11,012 | $32,000 | 0.00% |
| Capital Advisors, Ltd. LLC | 24 | $0 | 0.00% |